2021: Schweikert Voted To Increase Funds For The U.S. Anti-Doping Agency Starting In FY 2022 From $15.5 Million To $23.7 Million By FY 2030. In April 2021, Schweikert voted for the United States Anti-Doping Agency Reauthorization Act which would, according to Congressional Quarterly, "reauthorize the U.S. Anti-Doping Agency through fiscal 2030, authorizing $15.5 million for fiscal 2022, incrementally increasing to $23.7 million for fiscal 2030." The vote was on passage. The House passed the bill by a vote of 381-37. The Senate did not take substantive action on the bill. [House Vote 99, 4/14/21; Congressional Quarterly, 4/14/21; Congressional Actions, H.R. 172]
The Bill Would Have Certified The Testing Of International Athletes Participating In U.S. Competitions And Provided Educational Information To Athletes, Parents And Coaches On Integrity, Character Building And Healthy Performances. According to Congressional Quarterly, "task the agency with certifying the testing of international athletes competing in the U.S. and with promoting a 'positive youth sport experience' by providing educational materials on sportsmanship, character building and healthy performance for athletes, parents and coaches." [Congressional Quarterly, 4/14/21]
The Bill Would Have Required Several Federal Agencies To Collaborate With The U.S. Anti-Doping Agency By Sharing Information Regarding Performance-Enhancing Drug Prohibition And Prevention. According to Congressional Quarterly, "require the Judiciary Department, Homeland Security Department, and Food and Drug Administration to coordinate with the agency by sharing information related to prohibiting or preventing the use of performance-enhancing drugs or methods." [Congressional Quarterly, 4/14/21]